Positive opinion for Novo Nordisk’s Sogroya
26th May 2023 Uncategorised 0Therapy has been developed for use among children and adolescents with growth hormone deficiency
More: Positive opinion for Novo Nordisk’s Sogroya
Source: News
Therapy has been developed for use among children and adolescents with growth hormone deficiency
More: Positive opinion for Novo Nordisk’s Sogroya
Source: News
© 1994 - 2026 B.M. Pharmaceuticals